Citation Impact
Citing Papers
A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression
2005 StandoutNobel
The Molecular Genetics of Human Hemoglobin
1984
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
MYC on the Path to Cancer
2012 Standout
The Systemic Amyloidoses
1997 Standout
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia
2012
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
The β-Thalassemias
1999 Standout
Indispensable Role of the Runx1-Cbfβ Transcription Complex for In Vivo-Suppressive Function of FoxP3+ Regulatory T Cells
2009 StandoutNobel
Transcription factors in myeloid development: balancing differentiation with transformation
2007
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Bcr–Abl variants: biological and clinical aspects
2002
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
2008 Standout
Cancer Epigenetics: From Mechanism to Therapy
2012 Standout
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
2014 Standout
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
2010
APC mutations occur early during colorectal tumorigenesis
1992 StandoutNature
Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression
2000
The Epigenomics of Cancer
2007 Standout
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
The Molecular Basis of Leukemia
1994
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The Biology of Chronic Myeloid Leukemia
1999
DNA triple helices: Biological consequences and therapeutic potential
2008
Oncogenes and signal transduction
1991 Standout
Molecular characterization of a novel form of (A ) -thalassemia, deletion with a 3' breakpoint close to those of HPFH-3 and HPFH-4: insights for a common regulatory mechanism
1988
Molecular themes in oncogenesis
1991 StandoutNobel
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas
2002
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
Molecular analysis of deletions in the human β-globin gene cluster: Deletion junctions and locations of breakpoints
1990 StandoutNobel
MicroRNA signatures in human cancers
2006 Standout
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.
2004
Down's syndrome
2003 Standout
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
2000 StandoutNature
Cytokine Signaling in 2002
2002 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Inhibition of touch cell fate by egl-44 and egl-46 in C. elegans
2001 StandoutNobel
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Position-independent, high-level expression of the human β-globin gene in transgenic mice
1987 Standout
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
AUUUA Is Not Sufficient To Promote Poly(A) Shortening and Degradation of an mRNA: the Functional Sequence within AU-Rich Elements May Be UUAUUUA(U/A)(U/A)
1994
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
2000
A gene deletion ending within a complex array of repeated sequences 3' to the human beta-globin gene cluster.
1986 StandoutNobel
Nucleotide sequence of 16-kilobase pairs of DNA 5' to the human epsilon-globin gene.
1985 StandoutNobel
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
1995 StandoutNobel
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
2000
Comparison of Quantitative Reverse Transcription-PCR to Viral Culture for Assessment of Respiratory Syncytial Virus Shedding
2003
Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen.
1990 StandoutNobel
Memory Suppressor Genes: Inhibitory Constraints on the Storage of Long-Term Memory
1998 StandoutScienceNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia
1996
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
1997
Molecular comparison of delta beta-thalassemia and hereditary persistence of fetal hemoglobin DNAs: evidence of a regulatory area?
1982
A ChineseGγ+(Aγδβ)0thalassemia deletion: comparison to other deletions in the human β-globin gene cluster and sequence analysis of the breakpoints
1985 StandoutNobel
Separation by hybrid isoelectric focusing of normal human plasma transthyretin (prealbumin) and a variant with a methionine for valine substitution associated with familial amyloidotic polyneuropathy
1986
Stat5a/b contribute to interleukin 7–induced B-cell precursor expansion, but abl- andbcr/abl-induced transformation are independent of Stat5
2000
Polycythemia vera: myths, mechanisms, and management
2002
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
1990 Science
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Growth Factors and Cancer
1991 StandoutScience
Establishment of a peripheral T-cell lymphoma cell line showing amplification of the c-myc oncogene.
1988 StandoutNobel
Developmental genetics of the human haemoglobins
1983
Stat5a/b contribute to interleukin 7–induced B-cell precursor expansion, but abl- andbcr/abl-induced transformation are independent of Stat5
2000
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
The silent carrier allele: β thalassemia without a mutation in the β-globin gene or its immediate flanking regions
1984 StandoutNobel
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age
1995
The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster
1989
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of Angelo Guerrasio being referenced
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
2002
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts
2002
BCR/ABL rearrangement and leukemia phenotype
1999
Polyclonal haemopoieses associated with long‐term persistence of the AML1‐ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission
1995
Increase in platelet count in older, poor‐risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all‐trans retinoic acid
2005
Molecular Defects Associated with the Acute Phase CML
1993
A new Taql polymorphism in the p53 gene
1992
The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occurring in children with Down syndrome
1997
PH Positive Acute Lymphoblastic Leukemia in Adults: Molecular and Clinical Studies
1995
Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation
1993
Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
1992
Hemoglobin Expression in Clones of K562 Cell Line
1982
Polymorphism of human fetal haemoglobin studied by isoelectric focusing
1980
Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.
1993
Embryonic and fetal hemoglobin synthesis in K562 cell line.
1981
Italian type of deletional hereditary persistence of fetal hemoglobin
1986
Genetic regulation of ? gene expression: Study of the interaction of ?-thalassemia with heterocellular HPFH
1981
Variability of the molecular defects corresponding to the presence of a Philadelphia chromosome in human hematologic malignancies
1988
Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias
2003
Expression of GATA-1 mRNA in human myeloid leukemic cells.
1994
A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability.
1990
3' c-myc rearrangement in a human leukemic T-cell line.
1986